Correction of Incorrect Adverse Event Reporting Telephone Number - June 2016
Pediatric Use and Potential for QT and PR Interval Prolongation - Feb 2013
QT and PR Potential Drug Interactions - Nov 2010
Update to Package Insert - Feb 2008
Discontinue Soft-Gel Formulation of Saquinavir - May 2005
INVIRASE(R) Capsules (200 mg)
INVIRASE(R) F.C. Tablets (500 mg)
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.